Your browser doesn't support javascript.
loading
Loss of function mutations in EPHB4 are responsible for vein of Galen aneurysmal malformation.
Vivanti, Alexandre; Ozanne, Augustin; Grondin, Cynthia; Saliou, Guillaume; Quevarec, Loic; Maurey, Helène; Aubourg, Patrick; Benachi, Alexandra; Gut, Marta; Gut, Ivo; Martinovic, Jelena; Sénat, Marie Victoire; Tawk, Marcel; Melki, Judith.
Afiliação
  • Vivanti A; Institut National de la Santé et de la Recherche Médicale (Inserm) UMR-1169 and University Paris Sud, Le Kremlin Bicêtre, 94276, France.
  • Ozanne A; Department of Interventional Neuroradiology, National Reference Center for Paediatric Neurovascular Malformation, Assistance publique des Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin-Bicêtre, 94276, France.
  • Grondin C; Institut National de la Santé et de la Recherche Médicale (Inserm) UMR-1169 and University Paris Sud, Le Kremlin Bicêtre, 94276, France.
  • Saliou G; Department of Diagnostic and Interventional Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital, Lausanne, CH-1011, Switzerland.
  • Quevarec L; Institut National de la Santé et de la Recherche Médicale (Inserm) UMR-1169 and University Paris Sud, Le Kremlin Bicêtre, 94276, France.
  • Maurey H; Department of Paediatric Neurology, Hôpital Bicêtre, Assistance publique des Hôpitaux de Paris, Le Kremlin-Bicêtre, 94276, France.
  • Aubourg P; Department of Paediatric Neurology, Hôpital Bicêtre, Assistance publique des Hôpitaux de Paris, Le Kremlin-Bicêtre, 94276, France.
  • Benachi A; Department of Obstetrics and Gynecology, Hôpital Antoine-Béclère, Assistance publique des Hôpitaux de Paris, 92140, Clamart, France.
  • Gut M; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, 08028, Barcelona, Spain.
  • Gut I; Universitat Pompeu Fabra, 08002, Barcelona, Spain.
  • Martinovic J; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, 08028, Barcelona, Spain.
  • Sénat MV; Universitat Pompeu Fabra, 08002, Barcelona, Spain.
  • Tawk M; Unit of Fetal Pathology, Hôpital Antoine-Béclère, Assistance publique des Hôpitaux de Paris, 92140, Clamart, France.
  • Melki J; Department of Obstetrics and Gynecology, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris, Le Kremlin-Bicêtre, 94276, France.
Brain ; 141(4): 979-988, 2018 04 01.
Article em En | MEDLINE | ID: mdl-29444212
ABSTRACT
See Meschia (doi10.1093/brain/awy066) for a scientific commentary on this article.Vein of Galen aneurysmal malformation is a congenital anomaly of the cerebral vasculature representing 30% of all paediatric vascular malformations. We conducted whole exome sequencing in 19 unrelated patients presenting this malformation and subsequently screened candidate genes in a cohort of 32 additional patients using either targeted exome or Sanger sequencing. In a cohort of 51 patients, we found five affected individuals with heterozygous mutations in EPHB4 including de novo frameshift (p.His191Alafs*32) or inherited deleterious splice or missense mutations predicted to be pathogenic by in silico tools. Knockdown of ephb4 in zebrafish embryos leads to specific anomalies of dorsal cranial vessels including the dorsal longitudinal vein, which is the orthologue of the median prosencephalic vein and the embryonic precursor of the vein of Galen. This model allowed us to investigate EPHB4 loss-of-function mutations in this disease by the ability to rescue the brain vascular defect in knockdown zebrafish co-injected with wild-type, but not truncated EPHB4, mimicking the p.His191Alafs mutation. Our data showed that in both species, loss of function mutations of EPHB4 result in specific and similar brain vascular development anomalies. Recently, EPHB4 germline mutations have been reported in non-immune hydrops fetalis and in cutaneous capillary malformation-arteriovenous malformation. Here, we show that EPHB4 mutations are also responsible for vein of Galen aneurysmal malformation, indicating that heterozygous germline mutations of EPHB4 result in a large clinical spectrum. The identification of EPHB4 pathogenic mutations in patients presenting capillary malformation or vein of Galen aneurysmal malformation should lead to careful follow-up of pregnancy of carriers for early detection of anomaly of the cerebral vasculature in order to propose optimal neonatal care. Endovascular embolization indeed greatly improved the prognosis of patients.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor EphB4 / Malformações da Veia de Galeno / Mutação Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor EphB4 / Malformações da Veia de Galeno / Mutação Idioma: En Ano de publicação: 2018 Tipo de documento: Article